QT
PCVX icon

Quantbot Technologies’s Vaxcyte PCVX Stock Holding History

Quantbot Technologies’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-5,399
Closed -$249K – 2048
2025
Q4 		$249K Buy
+5,399
New +$241K 0.01% 1176
2025
Q3 		– Sell
-6,821
Closed -$222K – 2023
2025
Q2 		$222K Buy
+6,821
New +$224K 0.01% 1208
2024
Q2 		– Sell
-57
Closed -$3.89K – 1800
2024
Q1 		$3.89K Buy
+57
New +$3.95K ﹤0.01% 1487
2023
Q1 		– Sell
-22,100
Closed -$1.06M – 1936
2022
Q4 		$1.06M Buy
+22,100
New +$867K 0.08% 364
2022
Q1 		– Sell
-1,800
Closed -$42K – 1956
2021
Q4 		$42K Sell
1,800
-1,500
-45% -$34.9K ﹤0.01% 1070
2021
Q3 		$83K Buy
3,300
+1,800
+120% +$43.6K 0.01% 1009
2021
Q2 		$33K Buy
+1,500
New +$30.7K ﹤0.01% 1148

Other funds holding PCVX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return